Details for: CAPZA1

Gene ID: 829

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: CAPZA1

Ensembl ID: ENSG00000116489

Description: capping actin protein of muscle Z-line subunit alpha 1

Cell Significance Landscape

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD14-low, CD16-positive monocyte CL0002396
    CSI 81.12
    rCSI 62.5%
    PRS 11.72
  • myeloid leukocyte CL0000766
    CSI 53.55
    rCSI 49.41%
    PRS 13.12
  • extravillous trophoblast CL0008036
    CSI 48.19
    rCSI 59.62%
    PRS 11.36
  • Hofbauer cell CL3000001
    CSI 42.87
    rCSI 80.94%
    PRS 16.05
  • common dendritic progenitor CL0001029
    CSI 40.63
    rCSI 50.99%
    PRS 16.47
  • intermediate monocyte CL0002393
    CSI 31.57
    rCSI 47.64%
    PRS 12.76
  • elicited macrophage CL0000861
    CSI 30.54
    rCSI 28.04%
    PRS 14.81
  • promonocyte CL0000559
    CSI 28.66
    rCSI 49.11%
    PRS 17.31
  • BEST4+ enteroycte CL4030026
    CSI 24.18
    rCSI 30.08%
    PRS 13.69
  • myeloid dendritic cell CL0000782
    CSI 22.21
    rCSI 32.17%
    PRS 19.04
  • granulocyte monocyte progenitor cell CL0000557
    CSI 21.91
    rCSI 18.97%
    PRS 14.42
  • placental villous trophoblast CL2000060
    CSI 16.71
    rCSI 25.81%
    PRS 12.12
  • endothelial cell of placenta CL0009092
    CSI 15.72
    rCSI 77.49%
    PRS 17.58
  • promyelocyte CL0000836
    CSI 15.71
    rCSI 22.65%
    PRS 18
  • colon macrophage CL0009038
    CSI 14.47
    rCSI 66.83%
    PRS 26.7
  • memory T cell CL0000813
    CSI 13.45
    rCSI 25.91%
    PRS 28.87
  • pancreatic acinar cell CL0002064
    CSI 12.7
    rCSI 16.87%
    PRS 14.15
  • intestinal epithelial cell CL0002563
    CSI 12.05
    rCSI 12.59%
    PRS 13.61
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 12.02
    rCSI 72.75%
    PRS 28.71
  • common myeloid progenitor CL0000049
    CSI 11.98
    rCSI 9.69%
    PRS 12.77
  • large pre-B-II cell CL0000957
    CSI 11.55
    rCSI 32.98%
    PRS 22.29
  • fraction A pre-pro B cell CL0002045
    CSI 10.98
    rCSI 12.57%
    PRS 26.52
  • germinal center B cell CL0000844
    CSI 10.58
    rCSI 31.54%
    PRS 31.91
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 10.45
    rCSI 53.98%
    PRS 25.4
  • plasmablast CL0000980
    CSI 10.17
    rCSI 8%
    PRS 15.36
  • transitional stage B cell CL0000818
    CSI 9.19
    rCSI 30.1%
    PRS 36.01
  • type B pancreatic cell CL0000169
    CSI 7.88
    rCSI 17.45%
    PRS 12.04
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 7.69
    rCSI 6.95%
    PRS 11.44
  • fallopian tube secretory epithelial cell CL4030006
    CSI 7.5
    rCSI 7.22%
    PRS 13.4
  • stem cell CL0000034
    CSI 7.07
    rCSI 6.81%
    PRS 8.94
  • mature alpha-beta T cell CL0000791
    CSI 7.05
    rCSI 25.51%
    PRS 22.19
  • conventional dendritic cell CL0000990
    CSI 6.73
    rCSI 5.61%
    PRS 37.34
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 6.69
    rCSI 6.82%
    PRS 18.49
  • alveolar macrophage CL0000583
    CSI 6.46
    rCSI 10.65%
    PRS 15.06
  • hematopoietic stem cell CL0000037
    CSI 6.44
    rCSI 4.28%
    PRS 15.41
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 5.96
    rCSI 23.2%
    PRS 21.19
  • helper T cell CL0000912
    CSI 5.86
    rCSI 8.29%
    PRS 18.08
  • myeloid dendritic cell, human CL0001057
    CSI 5.46
    rCSI 30.73%
    PRS 40.41
  • enterocyte of epithelium of large intestine CL0002071
    CSI 5.3
    rCSI 27.84%
    PRS 22.92
  • transit amplifying cell of small intestine CL0009012
    CSI 4.96
    rCSI 21.77%
    PRS 24.11
  • eosinophil CL0000771
    CSI 4.78
    rCSI 31.35%
    PRS 33.35
  • foveolar cell of stomach CL0002179
    CSI 4.57
    rCSI 9.74%
    PRS 20.85
  • paneth cell CL0000510
    CSI 4.44
    rCSI 6.55%
    PRS 20.38
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 4.44
    rCSI 5.81%
    PRS 18.11
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 4.41
    rCSI 6.01%
    PRS 30.99
  • macrophage CL0000235
    CSI 4.28
    rCSI 7.78%
    PRS 49.03
  • pancreatic stellate cell CL0002410
    CSI 4.21
    rCSI 24.48%
    PRS 19.45
  • colon epithelial cell CL0011108
    CSI 3.95
    rCSI 4.14%
    PRS 12.06
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 3.93
    rCSI 14.13%
    PRS 7.06
  • CD4-positive helper T cell CL0000492
    CSI 3.81
    rCSI 2.88%
    PRS 17.87
  • intestinal crypt stem cell of colon CL0009043
    CSI 3.66
    rCSI 27.45%
    PRS 23.68
  • mature T cell CL0002419
    CSI 3.55
    rCSI 2.76%
    PRS 18.61
  • goblet cell CL0000160
    CSI 3.34
    rCSI 3.15%
    PRS 13.53
  • inflammatory macrophage CL0000863
    CSI 3.15
    rCSI 5.38%
    PRS 25.95
  • dendritic cell CL0000451
    CSI 3.02
    rCSI 3.72%
    PRS 40.43
  • colon goblet cell CL0009039
    CSI 2.98
    rCSI 7.07%
    PRS 19.48
  • blood vessel smooth muscle cell CL0019018
    CSI 2.94
    rCSI 23.94%
    PRS 13.36
  • non-classical monocyte CL0000875
    CSI 2.91
    rCSI 4.66%
    PRS 39.08
  • enterocyte CL0000584
    CSI 2.82
    rCSI 4.55%
    PRS 20.69
  • tuft cell of colon CL0009041
    CSI 2.8
    rCSI 6.52%
    PRS 27.28
  • monocyte CL0000576
    CSI 2.79
    rCSI 5.04%
    PRS 34.43
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 2.78
    rCSI 3.35%
    PRS 15.21
  • tissue-resident macrophage CL0000864
    CSI 2.71
    rCSI 12.7%
    PRS 26.58
  • myeloid cell CL0000763
    CSI 2.71
    rCSI 11.15%
    PRS 40.88
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 2.7
    rCSI 7.28%
    PRS 16.66
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 2.66
    rCSI 2.46%
    PRS 23.5
  • secretory cell CL0000151
    CSI 2.63
    rCSI 2.74%
    PRS 13.25
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 2.52
    rCSI 7.44%
    PRS 15.8
  • precursor B cell CL0000817
    CSI 2.48
    rCSI 2.17%
    PRS 17.14
  • activated type II NK T cell CL0000931
    CSI 2.38
    rCSI 2.68%
    PRS 20.73
  • M cell of gut CL0000682
    CSI 2.34
    rCSI 2.49%
    PRS 22.92
  • epithelial cell of lung CL0000082
    CSI 2.29
    rCSI 1.9%
    PRS 12.2
  • memory B cell CL0000787
    CSI 2.28
    rCSI 2.25%
    PRS 48.01
  • mucosal invariant T cell CL0000940
    CSI 2.21
    rCSI 1.79%
    PRS 21.22
  • mature NK T cell CL0000814
    CSI 2.2
    rCSI 2.81%
    PRS 50.39
  • epithelial cell of esophagus CL0002252
    CSI 2.14
    rCSI 21.11%
    PRS 44.79
  • direct pathway medium spiny neuron CL4023026
    CSI 2.1
    rCSI 50.22%
    PRS 5.84
  • B-1 B cell CL0000819
    CSI 2.09
    rCSI 53.82%
    PRS 57.82
  • early lymphoid progenitor CL0000936
    CSI 2.05
    rCSI 1.8%
    PRS 14.52
  • naive B cell CL0000788
    CSI 1.99
    rCSI 1.71%
    PRS 22.68
  • hepatocyte CL0000182
    CSI 1.97
    rCSI 3.52%
    PRS 12.06
  • pro-B cell CL0000826
    CSI 1.95
    rCSI 1.62%
    PRS 12.93
  • indirect pathway medium spiny neuron CL4023029
    CSI 1.95
    rCSI 47%
    PRS 6.72
  • plasmacytoid dendritic cell CL0000784
    CSI 1.91
    rCSI 1.94%
    PRS 61.56
  • perivascular cell CL4033054
    CSI 1.88
    rCSI 2.57%
    PRS 14.69
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 1.87
    rCSI 1.96%
    PRS 38.31
  • Mueller cell CL0000636
    CSI 1.86
    rCSI 4.25%
    PRS 11.35
  • peripheral nervous system neuron CL2000032
    CSI 1.85
    rCSI 2.52%
    PRS 11.54
  • chondrocyte CL0000138
    CSI 1.83
    rCSI 2.91%
    PRS 11.08
  • bronchus fibroblast of lung CL2000093
    CSI 1.81
    rCSI 1.47%
    PRS 13.67
  • granulocyte CL0000094
    CSI 1.8
    rCSI 2.75%
    PRS 16.34
  • hepatic stellate cell CL0000632
    CSI 1.8
    rCSI 6.74%
    PRS 10.96
  • melanocyte CL0000148
    CSI 1.8
    rCSI 1.33%
    PRS 11.44
  • bronchial goblet cell CL1000312
    CSI 1.78
    rCSI 7.12%
    PRS 28.28
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.78
    rCSI 2.44%
    PRS 26.65
  • pancreatic D cell CL0000173
    CSI 1.76
    rCSI 1.74%
    PRS 14.07
  • basophil CL0000767
    CSI 1.75
    rCSI 3.71%
    PRS 26.19
  • myofibroblast cell CL0000186
    CSI 1.75
    rCSI 2.42%
    PRS 18.58
  • conjunctival epithelial cell CL1000432
    CSI 1.74
    rCSI 2.66%
    PRS 12.94
  • double negative thymocyte CL0002489
    CSI 1.74
    rCSI 1.21%
    PRS 15.15
  • parietal epithelial cell CL1000452
    CSI -6.1
    rCSI -16.2%
    PRS 11.0%
  • renal beta-intercalated cell CL0002201
    CSI -5.5
    rCSI -13.1%
    PRS 15.5%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI -1.9
    rCSI -1.9%
    PRS 20.3%
  • adventitial cell CL0002503
    CSI -1.1
    rCSI -2.7%
    PRS 20.1%
  • tracheobronchial smooth muscle cell CL0019019
    CSI -1.1
    rCSI -1.9%
    PRS 17.1%
  • nasal mucosa goblet cell CL0002480
    CSI -1.1
    rCSI -1.2%
    PRS 19.1%
  • group 3 innate lymphoid cell CL0001071
    CSI -1.0
    rCSI -0.7%
    PRS 13.4%
  • cardiac neuron CL0010022
    CSI -0.9
    rCSI -3.0%
    PRS 9.2%
  • dopaminergic neuron CL0000700
    CSI -0.9
    rCSI -5.1%
    PRS 5.3%
  • periportal region hepatocyte CL0019026
    CSI -0.5
    rCSI -2.1%
    PRS 18.1%
  • lung pericyte CL0009089
    CSI -0.5
    rCSI -1.3%
    PRS 15.4%
  • ON-bipolar cell CL0000749
    CSI -0.5
    rCSI -0.7%
    PRS 15.8%
  • platelet CL0000233
    CSI -0.2
    rCSI -0.9%
    PRS 27.0%
  • retinal cone cell CL0000573
    CSI -0.1
    rCSI -0.2%
    PRS 10.0%
  • kidney connecting tubule epithelial cell CL1000768
    CSI -0.1
    rCSI -0.1%
    PRS 9.9%
  • respiratory goblet cell CL0002370
    CSI 0.0
    rCSI 0.4%
    PRS 24.9%
  • regular ventricular cardiac myocyte CL0002131
    CSI 0.1
    rCSI 0.4%
    PRS 10.1%
  • B-2 B cell CL0000822
    CSI 0.1
    rCSI 1.2%
    PRS 61.5%
  • cytotoxic T cell CL0000910
    CSI 0.1
    rCSI 0.4%
    PRS 18.9%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 0.1
    rCSI 0.1%
    PRS 28.1%
  • amacrine cell CL0000561
    CSI 0.1
    rCSI 0.2%
    PRS 10.1%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.1
    rCSI 0.5%
    PRS 43.0%
  • retina horizontal cell CL0000745
    CSI 0.1
    rCSI 0.2%
    PRS 12.1%
  • cerebral cortex neuron CL0010012
    CSI 0.1
    rCSI 0.5%
    PRS 13.4%
  • duct epithelial cell CL0000068
    CSI 0.1
    rCSI 0.2%
    PRS 13.7%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 0.2
    rCSI 1.7%
    PRS 48.7%
  • OFF-bipolar cell CL0000750
    CSI 0.2
    rCSI 0.2%
    PRS 21.1%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.2
    rCSI 0.8%
    PRS 16.9%
  • decidual natural killer cell, human CL0002343
    CSI 0.2
    rCSI 1.7%
    PRS 68.4%
  • tracheobronchial serous cell CL0019001
    CSI 0.2
    rCSI 0.8%
    PRS 24.7%
  • forebrain radial glial cell CL0013000
    CSI 0.2
    rCSI 0.6%
    PRS 18.9%
  • regular atrial cardiac myocyte CL0002129
    CSI 0.2
    rCSI 0.6%
    PRS 13.8%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.2
    rCSI 0.9%
    PRS 44.5%
  • epithelial cell of urethra CL1000296
    CSI 0.2
    rCSI 5.3%
    PRS 40.7%
  • podocyte CL0000653
    CSI 0.2
    rCSI 1.0%
    PRS 12.8%
  • renal interstitial pericyte CL1001318
    CSI 0.2
    rCSI 0.6%
    PRS 12.1%
  • ionocyte CL0005006
    CSI 0.3
    rCSI 0.3%
    PRS 11.9%
  • acinar cell of salivary gland CL0002623
    CSI 0.3
    rCSI 6.1%
    PRS 23.2%
  • lung ciliated cell CL1000271
    CSI 0.3
    rCSI 0.3%
    PRS 9.5%
  • centrilobular region hepatocyte CL0019029
    CSI 0.3
    rCSI 0.7%
    PRS 20.6%
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 0.3
    rCSI 0.9%
    PRS 20.1%
  • pancreatic epsilon cell CL0005019
    CSI 0.3
    rCSI 1.3%
    PRS 30.7%
  • squamous epithelial cell CL0000076
    CSI 0.3
    rCSI 0.7%
    PRS 16.4%
  • Cajal-Retzius cell CL0000695
    CSI 0.3
    rCSI 2.3%
    PRS 28.0%
  • pulmonary alveolar type 1 cell CL0002062
    CSI 0.3
    rCSI 1.8%
    PRS 17.2%
  • professional antigen presenting cell CL0000145
    CSI 0.3
    rCSI 1.1%
    PRS 47.3%
  • pancreatic PP cell CL0002275
    CSI 0.3
    rCSI 1.3%
    PRS 22.7%
  • brush cell CL0002204
    CSI 0.3
    rCSI 0.6%
    PRS 33.5%
  • glandular epithelial cell CL0000150
    CSI 0.3
    rCSI 0.9%
    PRS 25.3%
  • rod bipolar cell CL0000751
    CSI 0.3
    rCSI 0.6%
    PRS 10.8%
  • renal alpha-intercalated cell CL0005011
    CSI 0.3
    rCSI 0.5%
    PRS 17.1%
  • renal intercalated cell CL0005010
    CSI 0.3
    rCSI 3.1%
    PRS 74.4%
  • pulmonary ionocyte CL0017000
    CSI 0.4
    rCSI 0.4%
    PRS 16.3%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 0.4
    rCSI 0.4%
    PRS 7.4%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 0.4
    rCSI 0.6%
    PRS 7.6%
  • ciliated cell CL0000064
    CSI 0.4
    rCSI 0.6%
    PRS 13.2%
  • class switched memory B cell CL0000972
    CSI 0.4
    rCSI 0.3%
    PRS 21.7%
  • deuterosomal cell CL4033044
    CSI 0.4
    rCSI 1.3%
    PRS 21.8%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 0.4
    rCSI 0.7%
    PRS 19.8%
  • primitive red blood cell CL0002355
    CSI 0.4
    rCSI 2.1%
    PRS 24.2%
  • sncg GABAergic cortical interneuron CL4023015
    CSI 0.4
    rCSI 0.6%
    PRS 8.3%
  • retinal pigment epithelial cell CL0002586
    CSI 0.4
    rCSI 0.8%
    PRS 13.8%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.4
    rCSI 2.8%
    PRS 25.3%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 0.4
    rCSI 1.0%
    PRS 20.5%
  • retinal rod cell CL0000604
    CSI 0.4
    rCSI 0.7%
    PRS 12.8%
  • central nervous system neuron CL2000029
    CSI 0.4
    rCSI 3.1%
    PRS 6.6%
  • T-helper 17 cell CL0000899
    CSI 0.4
    rCSI 0.3%
    PRS 22.8%
  • luminal cell of prostate epithelium CL0002340
    CSI 0.4
    rCSI 2.3%
    PRS 23.3%
  • antibody secreting cell CL0000946
    CSI 0.4
    rCSI 1.9%
    PRS 50.3%
  • acinar cell CL0000622
    CSI 0.4
    rCSI 0.6%
    PRS 17.0%
  • OFF midget ganglion cell CL4033047
    CSI 0.4
    rCSI 8.8%
    PRS 10.9%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 0.4
    rCSI 1.1%
    PRS 11.8%
  • enteric smooth muscle cell CL0002504
    CSI 0.4
    rCSI 0.6%
    PRS 14.6%
  • fibroblast of breast CL4006000
    CSI 0.4
    rCSI 1.8%
    PRS 33.0%
  • thymocyte CL0000893
    CSI 0.5
    rCSI 1.6%
    PRS 40.1%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 0.5
    rCSI 0.8%
    PRS 7.6%
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 0.5
    rCSI 1.1%
    PRS 7.1%
  • small pre-B-II cell CL0000954
    CSI 0.5
    rCSI 0.4%
    PRS 26.7%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 0.5
    rCSI 0.7%
    PRS 12.1%
  • type L enteroendocrine cell CL0002279
    CSI 0.5
    rCSI 0.9%
    PRS 25.6%
  • mucous neck cell CL0000651
    CSI 0.5
    rCSI 0.7%
    PRS 20.8%
  • lung interstitial macrophage CL4033043
    CSI 0.5
    rCSI 1.1%
    PRS 26.6%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 0.5
    rCSI 7.5%
    PRS 32.0%
  • choroid plexus epithelial cell CL0000706
    CSI 0.5
    rCSI 0.8%
    PRS 10.0%
  • glycinergic amacrine cell CL4030028
    CSI 0.5
    rCSI 1.3%
    PRS 12.7%
  • mesodermal cell CL0000222
    CSI 0.5
    rCSI 0.6%
    PRS 12.8%
  • stromal cell of ovary CL0002132
    CSI 0.5
    rCSI 1.4%
    PRS 21.3%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.5
    rCSI 1.9%
    PRS 7.8%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 0.5
    rCSI 0.6%
    PRS 14.8%
  • basophil mast progenitor cell CL0002028
    CSI 0.5
    rCSI 2.7%
    PRS 46.6%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.5
    rCSI 0.6%
    PRS 17.1%
  • IgM plasma cell CL0000986
    CSI 0.5
    rCSI 2.3%
    PRS 56.2%
  • IgG plasma cell CL0000985
    CSI 0.5
    rCSI 0.6%
    PRS 22.2%
  • type EC enteroendocrine cell CL0000577
    CSI 0.5
    rCSI 1.9%
    PRS 21.2%
  • lung secretory cell CL1000272
    CSI 0.5
    rCSI 1.3%
    PRS 12.0%
  • H1 horizontal cell CL0004217
    CSI 0.5
    rCSI 2.1%
    PRS 18.2%
  • mucus secreting cell CL0000319
    CSI 0.5
    rCSI 0.9%
    PRS 16.7%
  • epicardial adipocyte CL1000309
    CSI 0.5
    rCSI 1.8%
    PRS 15.7%
  • ON parasol ganglion cell CL4033052
    CSI 0.5
    rCSI 7.7%
    PRS 9.0%
  • mature B cell CL0000785
    CSI 0.5
    rCSI 0.5%
    PRS 16.0%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [CAPZA1](/details-gene/829) encodes the alpha-1 subunit of the F-actin-capping protein complex, a heterodimer that binds to the fast-growing barbed ends of actin filaments, thereby regulating actin polymerization and cytoskeleton dynamics. Its function is fundamental to processes requiring cellular motility, structural integrity, and morphological changes. **Overall**, expression data reveals that [CAPZA1](/details-gene/829) is a highly significant gene in cells of the myeloid lineage, particularly [CD14-low, CD16-positive monocyte](/details-cell/CL0002396) and general [myeloid leukocyte](/details-cell/CL0000766) populations. This specific expression pattern, combined with its role in actin organization, suggests a critical function in the immune surveillance, phagocytosis, and migration characteristic of these cells. Additionally, its prominent expression in placental cells like [extravillous trophoblast](/details-cell/CL0008036) points towards an important role in embryonic development and implantation. ## Cellular Roles and Expression Landscape The expression profile of [CAPZA1](/details-gene/829) strongly indicates a specialized role within the hematopoietic system, with a clear bias towards the myeloid compartment. **Overall**, its most significant expression is observed in [CD14-low, CD16-positive monocyte](/details-cell/CL0002396) (CSI: 81.12), followed by a broader signature across [myeloid leukocyte](/details-cell/CL0000766) (CSI: 53.55) populations and their progenitors, including [common dendritic progenitor](/details-cell/CL0001029) and [promonocyte](/details-cell/CL0000559). This pattern extends to terminally differentiated phagocytes such as [Hofbauer cell](/details-cell/CL3000001) (CSI: 42.87) and [elicited macrophage](/details-cell/CL0000861) (CSI: 30.54), underscoring its importance in the functional activities of these key innate immune cells, which rely heavily on dynamic cytoskeletal rearrangement. Beyond the immune system, [CAPZA1](/details-gene/829) also demonstrates high significance in specialized placental cells, namely [extravillous trophoblast](/details-cell/CL0008036) (CSI: 48.19) and [placental villous trophoblast](/details-cell/CL2000060) (CSI: 16.71). This suggests a role in the invasive and structural functions of the placenta during pregnancy. Conversely, the gene's significance is notably low or negative in a wide range of other cell types. Its lack of expression in various neuronal cells (e.g., [cardiac neuron](/details-cell/CL0010022), [dopaminergic neuron](/details-cell/CL0000700)), certain epithelial cells ([parietal epithelial cell](/details-cell/CL1000452)), and lymphoid cells like [CD4-positive, CD25-positive, alpha-beta regulatory T cell](/details-cell/CL0000792) defines its specificity and points to a specialized function outside of these lineages, reinforcing its primary association with myeloid and placental biology. ## Pathways and Molecular Function The molecular functions of [CAPZA1](/details-gene/829) are intrinsically linked to its role as a core component of the cytoskeleton. Gene Ontology annotations confirm its involvement in [Actin cytoskeleton organization (GO:0030036)](https://www.ebi.ac.uk/QuickGO/term/GO:0030036), driven by its specific molecular function of [Barbed-end actin filament capping (GO:0051016)](https://www.ebi.ac.uk/QuickGO/term/GO:0051016) and [Actin binding (GO:0003779)](https://www.ebi.ac.uk/QuickGO/term/GO:0003779). By controlling the growth of actin filaments, it influences cell shape, adhesion, and movement. Its participation in the [F-actin capping protein complex (GO:0008290)](https://www.ebi.ac.uk/QuickGO/term/GO:0008290) is central to this activity. Consistent with its high expression in immune cells, [CAPZA1](/details-gene/829) is annotated in broad immune-related Reactome pathways, including the [Immune system (R-HSA-168256)](https://reactome.org/content/detail/R-HSA-168256), [Innate immune system (R-HSA-168249)](https://reactome.org/content/detail/R-HSA-168249), and [Cytokine signaling in immune system (R-HSA-1280215)](https://reactome.org/content/detail/R-HSA-1280215). These connections are likely indirect, reflecting the necessity of a dynamic cytoskeleton for immune cells to execute their functions, such as migration, antigen presentation ([Mhc class ii antigen presentation (R-HSA-2132295)](https://reactome.org/content/detail/R-HSA-2132295)), and responding to stimuli ([Cellular responses to stimuli (R-HSA-8953897)](https://reactome.org/content/detail/R-HSA-8953897)). Its association with [Hemostasis (R-HSA-109582)](https://reactome.org/content/detail/R-HSA-109582) may relate to the role of myeloid cells and platelets in clotting and wound healing processes, which also depend on cytoskeletal control. ## Research Directions The specific and high expression of [CAPZA1](/details-gene/829) in myeloid and placental cells, coupled with its fundamental role in actin dynamics, suggests several avenues for future research into its role in health and disease. ### Proposed Hypotheses: 1. **Impaired macrophage function in inflammatory disease:** Given its high significance in monocytes and macrophages, it is hypothesized that altered expression or function of [CAPZA1](/details-gene/829) contributes to defective macrophage migration and phagocytosis in chronic inflammatory conditions or during tumor infiltration, thereby modulating the tissue microenvironment. 2. **Role in placental development and pathology:** The prominent expression in [extravillous trophoblast](/details-cell/CL0008036) suggests a critical role in trophoblast invasion of the uterine wall. It is hypothesized that insufficient [CAPZA1](/details-gene/829) function could lead to shallow placental implantation, a key pathological feature of pre-eclampsia. 3. **Regulation of dendritic cell maturation:** As [CAPZA1](/details-gene/829) is highly expressed in [common dendritic progenitor](/details-cell/CL0001029) and [myeloid dendritic cell](/details-cell/CL0000782), it is hypothesized that it regulates the dramatic morphological changes that dendritic cells undergo during maturation and antigen presentation, and its dysregulation could impair the initiation of adaptive immune responses. ### Key Experimental Approach: To test the hypothesis regarding macrophage function (Hypothesis 1), a targeted genetic approach could be employed. Specifically, CRISPR-Cas9 could be used to knock out [CAPZA1](/details-gene/829) in a human monocytic cell line (e.g., THP-1) or in primary human monocytes. Following differentiation into macrophages, these [CAPZA1](/details-gene/829)-deficient cells and their wild-type counterparts could be assessed in parallel. Key functional assays would include: (i) a phagocytosis assay using fluorescently labeled zymosan particles or E. coli, quantified by flow cytometry or microscopy, and (ii) a transwell migration assay to measure chemotaxis in response to a chemoattractant like C5a or CCL2. A significant reduction in phagocytic capacity or migratory ability in knockout cells would provide direct evidence for its essential role in macrophage function. ### Therapeutic Potential: As an intracellular structural protein essential for a ubiquitous cellular process, [CAPZA1](/details-gene/829) is unlikely to be a viable direct therapeutic target for inhibition or activation, as this would likely cause significant toxicity. However, its high and specific expression in myeloid cells suggests it could serve as a valuable biomarker. For example, quantifying [CAPZA1](/details-gene/829) expression levels in tumor-associated macrophages (TAMs) could potentially correlate with their migratory or invasive phenotype, offering prognostic value in cancer. Furthermore, understanding the pathways that regulate [CAPZA1](/details-gene/829) in these cells may reveal more druggable upstream targets for modulating myeloid cell function in disease.

Genular Protein ID: 1572380775

Symbol: CAZA1_HUMAN

Name: F-actin-capping protein subunit alpha-1

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9331217

Title: Vertebrates have conserved capping protein alpha isoforms with specific expression patterns.

PubMed ID: 9331217

DOI: 10.1002/(sici)1097-0169(1997)38:2<120::aid-cm2>3.0.co;2-b

PubMed ID: 16710414

Title: The DNA sequence and biological annotation of human chromosome 1.

PubMed ID: 16710414

DOI: 10.1038/nature04727

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19922875

Title: The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex.

PubMed ID: 19922875

DOI: 10.1016/j.devcel.2009.09.010

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 22891260

Title: Epithelial junction formation requires confinement of Cdc42 activity by a novel SH3BP1 complex.

PubMed ID: 22891260

DOI: 10.1083/jcb.201202094

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 30361697

Title: Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via beta-catenin.

PubMed ID: 30361697

DOI: 10.1038/s41556-018-0215-z

PubMed ID: 24951542

Title: A missense mutation in the PISA domain of HsSAS-6 causes autosomal recessive primary microcephaly in a large consanguineous Pakistani family.

PubMed ID: 24951542

DOI: 10.1093/hmg/ddu318

PubMed ID: 12470955

Title: Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.

PubMed ID: 12470955

DOI: 10.1016/s0022-2836(02)01152-x

PubMed ID: 12480931

Title: A novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complex.

PubMed ID: 12480931

DOI: 10.1074/jbc.m210622200

Sequence Information:

  • Length: 286
  • Mass: 32923
  • Checksum: 0F47ADAB6A3689DD
  • Sequence:
  • MADFDDRVSD EEKVRIAAKF ITHAPPGEFN EVFNDVRLLL NNDNLLREGA AHAFAQYNMD 
    QFTPVKIEGY EDQVLITEHG DLGNSRFLDP RNKISFKFDH LRKEASDPQP EEADGGLKSW 
    RESCDSALRA YVKDHYSNGF CTVYAKTIDG QQTIIACIES HQFQPKNFWN GRWRSEWKFT 
    ITPPTAQVVG VLKIQVHYYE DGNVQLVSHK DVQDSLTVSN EAQTAKEFIK IIENAENEYQ 
    TAISENYQTM SDTTFKALRR QLPVTRTKID WNKILSYKIG KEMQNA